GS
ANAC

GAM Systematic’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

GAM Systematic’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,202
Closed -$141K – 728
2015
Q3 		$141K Buy
+1,202
New +$157K 0.03% 533

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAM Systematic's ANAC Position: Q4 2015 in Review

GAM Systematic sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2015, closing a stake of 1,202 shares — an estimated $141K sold.

GAM Systematic first reported a position in ANAC in Q3 2015 and held it in 1 quarter. The position peaked at $141K in Q3 2015. 214 funds tracked by Wall St. Rank hold ANAC as of Q4 2015.

  • GAM Systematic reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2015 after selling out during the quarter.
  • GAM Systematic sold 1,202 ANACOR PHARMACEUTICALS INC COM shares in Q4 2015, an estimated $141K.
  • GAM Systematic first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 1 quarter.
  • GAM Systematic's ANACOR PHARMACEUTICALS INC COM position peaked at $141K in Q3 2015.
  • 214 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2015.

Based on GAM Systematic's 13F filing for Q4 2015, filed 12 Feb 2016.